The Pharmaceutical Research and Manufacturers of America has waded into the mifepristone controversy by filing an amicus brief – along with other industry stakeholders – asking for a reversal of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback